Vispring 0.5 Mg/Ml Eye Drops in Solution 1 Bottle 15 Ml

Vispring (0.5 Mg/Ml Eye Drops in Solution 1 Bottle 15 Ml)

ACTION AND MECHANISM

- Eye decongestant. Adrenergic, it acts by producing vasoconstriction at the conjunctival level and, as a consequence, reducing conjunctival congestion. The effects last approximately 6 hours.

INDICATIONS

- Temporary symptomatic relief of [CONJUNCTIVITIS] (stinging, [EYE IRRITATION], itching and excessive tearing) due to ocular allergies, minor irritations and non-specific catarrhal conjunctivitis.

POSOLOGY

- Adults and children over 6 years of age: 1 or 2 drops in each eye 2-3 times a day as needed. Maximum 4 times a day.

- Children from 2 to 6 years: always administer under strict medical supervision.

- Children < 2 years: contraindicated.

RULES FOR CORRECT ADMINISTRATION

- Wash your hands.

- Look up. Pull down the lower eyelid to make a pouch.

- Bring the dropper as close to the bag as possible without touching the eye. To avoid contamination of the medication, it is important that the tip of the applicator does not come into contact with any surface (including the eye).

- Apply the prescribed amount of eye drops to the bag. 

- Blink a couple of times to spread the drop over the entire ocular surface.

- Close your eye for about two minutes (do not close too tightly) or press the nasolacrimal edge to reduce systemic absorption. 

If another topical ophthalmic medication is being used, this medication should be administered at least ten minutes apart. Ophthalmic ointments should be administered last.

ADVICE TO THE PATIENT

- If relief is not obtained within 2 days, or if redness increases or persists, discontinue use and consult a doctor.

- Treatment should not exceed 7 days. Prolonged and frequent use can cause congestion and dry eyes.

- Because it contains benzalkonium chloride as an excipient (except in the case of a single-dose presentation), which can cause eye irritation and discolor or alter the color of soft contact lenses, it is recommended to avoid the use of this medication if the lenses are worn. contact lenses. The lenses must be removed before application and can be put in after at least 15 minutes after instilling this medication.

- If severe eye pain, headache, rapid changes in vision, rapid appearance of floaters, acute redness of the eye, pain after exposure to light or double vision occur, you should evaluate the clinical situation.

CONTRAINDICATIONS

- Allergy to the medication.

- [CLOSED ANGLE GLAUCOMA] or predisposition to it, since it can aggravate the disease.

- Children under 2 years old.

PRECAUTIONS

- It can mask symptoms in patients with [OPHTHALMOLOGICAL INFECTION].

- Given the possibility of systemic absorption, it should not be used indiscriminately in [ARTERIAL HYPERTENSION], [ANGINA PEST], [CORONARY INSUFFICIENCY], [HYPERTHYROIDISM], [DIABETES], [PHEOCHROMOCYTOMA].

- Patients under treatment with MAO inhibitors or other potential blood pressure elevators.

- Patients with sicca rhinitis and [KERATOCONJUNCTIVITIS].

PREGNANCY

Safety in animals: no animal studies have been performed.

Safety in humans: There are no adequate and well-controlled studies in humans. It is unknown whether tetrizoline ophthalmic can cause fetal harm when administered to pregnant women; possible systemic absorption must be taken into account. The use of this medication is only accepted in the absence of safer therapeutic alternatives.

Effects on fertility: no specific studies have been performed in humans.

LACTATION

Safety in animals: no data available.

Safety in humans: It is unknown whether tetrizolin is excreted in milk. The risk to infants cannot be excluded. A decision should be made whether to discontinue breast-feeding or to discontinue/discontinue treatment after considering the benefit of breast-feeding to the child and the benefit of treatment to the mother.

CHILDREN

Contraindicated use in children under 2 years of age. In children from 2 to 6 years old, use only under medical supervision. Children, especially younger children, may be more sensitive to toxic effects resulting from systemic absorption. Likewise, red eyes may appear in children due to illnesses that may require medical attention, such as allergies, fever, colds or measles. The use of tetrizoline eye drops is not recommended in children under 6 years of age. It is recommended to always use moderate doses for no more than 3 days.

ADVANCED AGE

No specific problems have been described in the elderly that require dosage readjustment.

ADVERSE REACTIONS

- Occasionally, [EYE IRRITATION], burning, [BLURRY VISION], [DRY EYE], [MYDRIASIS].

With excessive use or high doses: rebound congestion (redness and irritation).

- Exceptionally, signs of systemic absorption: headaches, palpitations, nervousness, nausea, sweating, headache, increased blood pressure and weakness.

ADVERSE REACTIONS RELATING TO EXCIPIENTS

- Cases of [CORNEAL CALCIFICATION] associated with the use of eye drops containing phosphates have been reported, very rarely, in some patients with significant involvement of the cornea.

Package Leaflet Vispring 0.5 Mg/Ml Eye Drops in Solution 1 Bottle 15 Ml